{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:39:09Z","timestamp":1793043549612,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijbiomac.2019.06.009","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T17:19:41Z","timestamp":1559582381000},"page":"1169-1175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Yeast (1\u202f\u2192\u202f3)-(1\u202f\u2192\u202f6)-\u03b2-d-glucan alleviates immunosuppression in gemcitabine-treated mice"],"prefix":"10.1016","volume":"136","author":[{"given":"Jin Sung","family":"Chae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngju","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hwan","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukchan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Seon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0005","first-page":"61","article-title":"Difluorodeoxyguanosine: cytotoxicity, metabolism, and actions on DNA synthesis in human leukemia cells","author":"Gandhi","year":"1995","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.06.009_bb0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00002820-199904000-00011","article-title":"Gemcitabine: a pharmacologic and clinical overview","volume":"22","author":"Barton-Burke","year":"1999","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0015","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0959-8049(96)00326-7","article-title":"Combination therapy with gemcitabine in non-small cell lung cancer","volume":"33","author":"Mosconi","year":"1997","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.06.009_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-4165(99)00209-3","article-title":"Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines","volume":"1474","author":"Van Moorsel","year":"2000","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"8","key":"10.1016\/j.ijbiomac.2019.06.009_bb0025","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1200\/JCO.1994.12.8.1527","article-title":"Gemcitabine: current status of phase I and II trials","volume":"12","author":"Kaye","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2019.06.009_bb0030","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1023\/A:1013163831194","article-title":"Gemcitabine-induced systemic capillary leak syndrome","volume":"12","author":"De Pas","year":"2001","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.06.009_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000421-200202000-00005","article-title":"Severe pulmonary toxicity in a patient treated with gemcitabine","volume":"25","author":"Rosado","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2019.06.009_bb0040","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/sj.bjc.6602564","article-title":"Preclinical relevance of dosing time for the therapeutic index of gemcitabine\u2013cisplatin","volume":"92","author":"Li","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.06.009_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9258(18)72984-0","article-title":"Anticomplementary factor in fresh yeast","volume":"137","author":"Pillemer","year":"1941","journal-title":"J. Biol. Chem."},{"issue":"3169","key":"10.1016\/j.ijbiomac.2019.06.009_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.122.3169.545","article-title":"Properdin system and immunity. II. Interaction and the properdin system with polysaccharides","volume":"122","author":"Pillemer","year":"1955","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ijbiomac.2019.06.009_bb0055","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.foodchem.2010.12.063","article-title":"Immunomodulatory effect of mushrooms on cytotoxic activity and cytokine production of intestinal lamina propria leukocytes does not necessarily depend on \u03b2-glucan contents","volume":"126","author":"Lee","year":"2011","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2019.06.009_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.fsi.2013.05.017","article-title":"Purification, characterization and functional analysis of a novel \u03b2-1, 3-glucan binding protein from green tiger shrimp Penaeus semisulcatus","volume":"35","author":"Sivakamavalli","year":"2013","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.fsi.2015.11.023","article-title":"Multifunctional role of \u03b2-1, 3 glucan binding protein purified from the haemocytes of blue swimmer crab Portunus pelagicus and in vitro antibacterial activity of its reaction product","volume":"48","author":"Anjugam","year":"2016","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.fsi.2017.07.007","article-title":"Role of purified \u03b2-1, 3 glucan binding protein (\u03b2-GBP) from Paratelphusa hydrodromus and their anti-inflammatory, antioxidant and antibiofilm properties","volume":"68","author":"Iswarya","year":"2017","journal-title":"Fish Shellfish Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.06.009_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-8722-2-25","article-title":"The effects of \u03b2-glucan on human immune and cancer cells","volume":"2","author":"Chan","year":"2009","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2019.06.009_bb0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1084\/jem.20021890","article-title":"Dectin-1 mediates the biological effects of \u03b2-glucans","volume":"197","author":"Brown","year":"2003","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2019.06.009_bb0085","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.intimp.2009.02.005","article-title":"Maitake \u03b2-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice","volume":"9","author":"Masuda","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2019.06.009_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004320050014","article-title":"Schedule dependent toxicity and efficacy of combined gemcitabine\/paclitaxel treatment in mouse adenocarcinoma","volume":"126","author":"Cividalli","year":"2000","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2019.06.009_bb0095","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2014new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijbiomac.2016.10.106","article-title":"Anti-tumor effects of (1\u2192 3)-\u03b2-d-glucan from Saccharomyces cerevisiae in S180 tumor-bearing mice","volume":"95","author":"Mo","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2019.06.009_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.critrevonc.2010.03.008","article-title":"Febrile neutropenia: a critical review of the initial management","volume":"78","author":"Klastersky","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2019.06.009_bb0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00520-010-0816-y","article-title":"Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?","volume":"18","author":"Aapro","year":"2010","journal-title":"Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.06.009_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.critrevonc.2009.01.003","article-title":"Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics","volume":"72","author":"Wingard","year":"2009","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.06.009_bb0120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.173.2.797","article-title":"Mechanism by which orally administered \u03b2-1, 3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models","volume":"173","author":"Hong","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2019.06.009_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/7403","article-title":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo","volume":"5","author":"Fernandez","year":"1999","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2019.06.009_bb0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.nutres.2012.09.011","article-title":"Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice","volume":"32","author":"Park","year":"2012","journal-title":"Nutr. Res."},{"issue":"21","key":"10.1016\/j.ijbiomac.2019.06.009_bb0135","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1158\/1078-0432.CCR-10-0820","article-title":"Orally administered particulate \u03b2-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer","volume":"16","author":"Li","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2019.06.009_bb0140","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1182\/blood-2008-05-158469","article-title":"C.R. e Sousa, Stimulation of dendritic cells via the dectin-1\/Syk pathway allows priming of cytotoxic T-cell responses","volume":"112","author":"LeibundGut-Landmann","year":"2008","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.ijbiomac.2019.06.009_bb0145","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1182\/blood-2011-02-339812","article-title":"Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived \u03b2-glucans","volume":"117","author":"Qi","year":"2011","journal-title":"Blood"},{"issue":"5813","key":"10.1016\/j.ijbiomac.2019.06.009_bb0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/291335a0","article-title":"Interleukin-2 augments natural killer cell activity","volume":"291","author":"Henney","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.06.009_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01742376","article-title":"Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity","volume":"31","author":"Hoover","year":"1990","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.ijbiomac.2019.06.009_bb0160","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.144.8.2999","article-title":"Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta","volume":"144","author":"Chung","year":"1990","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2019.06.009_bb0165","doi-asserted-by":"crossref","first-page":"G130","DOI":"10.1152\/ajpgi.1998.275.1.G130","article-title":"Kinetics of particle uptake in the domes of Peyer's patches","volume":"275","author":"Beier","year":"1998","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ijbiomac.2019.06.009_bb0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0074-7696(08)61346-7","article-title":"M cells in Peyer's patches of the intestine","author":"Gebert","year":"1996","journal-title":"Int. Rev. Cytol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2019.06.009_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.it.2010.12.003","article-title":"Inflammatory signals regulate hematopoietic stem cells","volume":"32","author":"Baldridge","year":"2011","journal-title":"Trends Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019326923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019326923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T04:46:16Z","timestamp":1694925976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019326923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"alternative-id":["S0141813019326923"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.009","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yeast (1\u202f\u2192\u202f3)-(1\u202f\u2192\u202f6)-\u03b2-d-glucan alleviates immunosuppression in gemcitabine-treated mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}